BACKGROUND: The BRCA1 gene is an important breast-cancer susceptibility gene. Promoter polymorphisms can alter the binding affinity of transcription factors, changing transcriptional activity and may affect susceptibility to disease. METHODS AND RESULTS: Using direct sequencing of the BRCA1 promoter region, we identified four polymorphisms c.-2804T-->C (rs799908:T-->C), c.-2265C-->T (rs11655505:C-->T), c.-2004A-->G (rs799906:A-->G) and c.-1896(ACA)(1)-->(ACA)(2) (rs8176071:(ACA)(1)-->(ACA)(2)) present in Hong Kong Chinese. Each polymorphism was studied independently and in combination by functional assays. Although all four variants significantly altered promoter activity, the c.-2265T allele had stronger binding than the C allele, and the most common mutant haplotype, which contains the c.-2265T allele, increased promoter activity by 70%. Risk association first tested in Hong Kong Chinese women with breast cancer and age-matched controls and replicated in a large population-based study of Shanghai Chinese, together totalling >3000 participants, showed that carriers of the c.-2265T allele had a reduced risk for breast cancer (combined odd ratio (OR) = 0.80, 95% CI 0.69 to 0.93; p = 0.003) which was more evident among women aged >or=45 years at first diagnosis of breast cancer and without a family history of breast cancer (combined OR = 0.75, 95% CI 0.61 to 0.91; p = 0.004). The most common haplotype containing the c.-2265T allele also showed significant risk association for women aged >or=45 years without a family history of breast cancer (OR = 0.64, 95% CI 0.46 to 0.89; p = 0.008). CONCLUSION: This comprehensive study of BRCA1 promoter polymorphisms found four variants that altered promoter activity and with the most significant contribution from c.-2265C-->T, which could affect susceptibility to breast cancer in the Chinese population. Its significance in other populations remains to be investigated.
BACKGROUND: The BRCA1 gene is an important breast-cancer susceptibility gene. Promoter polymorphisms can alter the binding affinity of transcription factors, changing transcriptional activity and may affect susceptibility to disease. METHODS AND RESULTS: Using direct sequencing of the BRCA1 promoter region, we identified four polymorphisms c.-2804T-->C (rs799908:T-->C), c.-2265C-->T (rs11655505:C-->T), c.-2004A-->G (rs799906:A-->G) and c.-1896(ACA)(1)-->(ACA)(2) (rs8176071:(ACA)(1)-->(ACA)(2)) present in Hong Kong Chinese. Each polymorphism was studied independently and in combination by functional assays. Although all four variants significantly altered promoter activity, the c.-2265T allele had stronger binding than the C allele, and the most common mutant haplotype, which contains the c.-2265T allele, increased promoter activity by 70%. Risk association first tested in Hong Kong Chinese women with breast cancer and age-matched controls and replicated in a large population-based study of Shanghai Chinese, together totalling >3000 participants, showed that carriers of the c.-2265T allele had a reduced risk for breast cancer (combined odd ratio (OR) = 0.80, 95% CI 0.69 to 0.93; p = 0.003) which was more evident among women aged >or=45 years at first diagnosis of breast cancer and without a family history of breast cancer (combined OR = 0.75, 95% CI 0.61 to 0.91; p = 0.004). The most common haplotype containing the c.-2265T allele also showed significant risk association for women aged >or=45 years without a family history of breast cancer (OR = 0.64, 95% CI 0.46 to 0.89; p = 0.008). CONCLUSION: This comprehensive study of BRCA1 promoter polymorphisms found four variants that altered promoter activity and with the most significant contribution from c.-2265C-->T, which could affect susceptibility to breast cancer in the Chinese population. Its significance in other populations remains to be investigated.
Authors: D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman Journal: Am J Hum Genet Date: 1998-03 Impact factor: 11.025
Authors: Y T Gao; X O Shu; Q Dai; J D Potter; L A Brinton; W Wen; T A Sellers; L H Kushi; Z Ruan; R M Bostick; F Jin; W Zheng Journal: Int J Cancer Date: 2000-07-15 Impact factor: 7.396
Authors: Ee Ming Wong; Melissa C Southey; Stephen B Fox; Melissa A Brown; James G Dowty; Mark A Jenkins; Graham G Giles; John L Hopper; Alexander Dobrovic Journal: Cancer Prev Res (Phila) Date: 2010-10-26
Authors: Beata Bielinska; Pawel Gaj; Anna Kluska; Dorota Nowakowska; Aneta Balabas; Michalina Dabrowska; Anna Niwinska; Jakub Gruchota; Renata Zub; Elzbieta Skasko; Jan Steffen; Jerzy Ostrowski; Janusz A Siedlecki Journal: Fam Cancer Date: 2013-12 Impact factor: 2.375
Authors: Wei Zheng; Ben Zhang; Qiuyin Cai; Hyuna Sung; Kyriaki Michailidou; Jiajun Shi; Ji-Yeob Choi; Jirong Long; Joe Dennis; Manjeet K Humphreys; Qin Wang; Wei Lu; Yu-Tang Gao; Chun Li; Hui Cai; Sue K Park; Keun-Young Yoo; Dong-Young Noh; Wonshik Han; Alison M Dunning; Javier Benitez; Daniel Vincent; Francois Bacot; Daniel Tessier; Sung-Won Kim; Min Hyuk Lee; Jong Won Lee; Jong-Young Lee; Yong-Bing Xiang; Ying Zheng; Wenjin Wang; Bu-Tian Ji; Keitaro Matsuo; Hidemi Ito; Hiroji Iwata; Hideo Tanaka; Anna H Wu; Chiu-chen Tseng; David Van Den Berg; Daniel O Stram; Soo Hwang Teo; Cheng Har Yip; In Nee Kang; Tien Y Wong; Chen-Yang Shen; Jyh-Cherng Yu; Chiun-Sheng Huang; Ming-Feng Hou; Mikael Hartman; Hui Miao; Soo Chin Lee; Thomas Choudary Putti; Kenneth Muir; Artitaya Lophatananon; Sarah Stewart-Brown; Pornthep Siriwanarangsan; Suleeporn Sangrajrang; Hongbing Shen; Kexin Chen; Pei-Ei Wu; Zefang Ren; Christopher A Haiman; Aiko Sueta; Mi Kyung Kim; Ui Soon Khoo; Motoki Iwasaki; Paul D P Pharoah; Wanqing Wen; Per Hall; Xiao-Ou Shu; Douglas F Easton; Daehee Kang Journal: Hum Mol Genet Date: 2013-03-27 Impact factor: 6.150
Authors: Amanda B Spurdle; Phillip J Whiley; Bryony Thompson; Bingjian Feng; Sue Healey; Melissa A Brown; Christopher Pettigrew; Christi J Van Asperen; Margreet G E M Ausems; Anna A Kattentidt-Mouravieva; Ans M W van den Ouweland; Annika Lindblom; Maritta H Pigg; Rita K Schmutzler; Christoph Engel; Alfons Meindl; Sandrine Caputo; Olga M Sinilnikova; Rosette Lidereau; Fergus J Couch; Lucia Guidugli; Thomas van Overeem Hansen; Mads Thomassen; Diana M Eccles; Kathy Tucker; Javier Benitez; Susan M Domchek; Amanda E Toland; Elizabeth J Van Rensburg; Barbara Wappenschmidt; Åke Borg; Maaike P G Vreeswijk; David E Goldgar Journal: J Med Genet Date: 2012-08 Impact factor: 6.318